Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,946 | 38,688 | 23,735 | N/A | 4,360 |
| Marketable Securities | 122,311 | 217,255 | 131,172 | N/A | 42,710 |
| Receivables | 4,050 | 4,931 | 1,636 | N/A | 3,250 |
| Inventories | 878 | 973 | 167 | N/A | 0 |
| Other current assets | 0 | 0 | 0 | 0 | 920 |
| TOTAL | $151,342 | $265,443 | $157,492 | $N/A | $51,240 |
| Non-Current Assets | |||||
| PPE Net | 11,652 | 8,395 | 4,263 | N/A | 6,820 |
| Intangibles | 14,734 | 17,435 | 26,825 | 0 | 0 |
| Other Non-Current Assets | 9,052 | 12,477 | 1,531 | 0 | 80 |
| TOTAL | $35,438 | $38,307 | $32,619 | $N/A | $6,900 |
| Total Assets | $186,780 | $303,750 | $190,111 | $N/A | $58,150 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,250 | 2,051 | 1,628 | N/A | 0 |
| Accounts payable and accrued liabilities | 2,444 | 1,206 | 1,113 | 0 | 1,100 |
| Accrued Expenses | 15,796 | 11,521 | 8,367 | N/A | 4,810 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1,180 |
| TOTAL | $21,493 | $15,301 | $11,108 | $N/A | $7,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,614 | 1,521 | 1,060 | N/A | 3,880 |
| Deferred Revenues | 1,003 | 523 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 115,100 | 175,000 | 0 | 0 | 0 |
| TOTAL | $121,804 | $178,892 | $1,060 | $N/A | $3,880 |
| Total Liabilities | $143,297 | $194,193 | $12,168 | $N/A | $10,990 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3 | 3 | N/A | N/A | N/A |
| Common Shares | 384,994 | 399,649 | 386,895 | N/A | 169,610 |
| Retained earnings | -340,455 | -290,552 | -210,279 | N/A | -122,070 |
| Other shareholders' equity | -1,056 | 460 | 1,327 | 0 | -380 |
| TOTAL | $43,483 | $109,557 | $177,943 | $N/A | $47,160 |
| Total Liabilities And Equity | $186,780 | $303,750 | $190,111 | $0 | $58,150 |